Acquisition of Specific Pathogen Free Live Animals
Solicitation number 26-58014
Publication date
Closing date and time 2026/05/26 14:00 EDT
Description
The Department of National Research Council Canada (NRC), Human Health Therapeutics Research Centre, requires the supply and delivery of Specific Pathogen‑Free (SPF) laboratory animals, or equivalent, required to support approved research protocols including mice, rats, hamsters, and rabbits.
All animals must meet specified criteria related to genotype, health status, sex, age, weight, and pregnancy status. They must also be housed and bred in full compliance with Canadian Council on Animal Care (CCAC) guidelines.
Contract duration
The estimated contract period will be 58 month(s), with a proposed start date of 2026/05/29.
Trade agreements
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Canada-Colombia Free Trade Agreement
-
Canada-Panama Free Trade Agreement
-
Canada-Honduras Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-Ukraine Free Trade Agreement (CUFTA)
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
None
Contact information
Contracting organization
- Organization
-
National Research Council of Canada (NRC)
- Address
-
1200 Montreal Road
Ottawa, ON, K1A0R6Canada
- Contracting authority
- Isabelle Fortin
- Phone
- (438) 466-3137
- Email
- isabelle.fortin@cnrc-nrc.gc.ca
- Address
-
6100 Royalmount Avenue
Montreal, QC, H4P 2R2Canada
Bidding details
| Document title | Amendment no. | Language | Unique downloads | Date added |
|---|---|---|---|---|
| 26-58014_ACAN_CharlesRiverLaboratories_ENG.pdf | 001 | EN | 18 | 2026/05/12 |
| 26-58014_ACAN_CharlesRiverLaboratories_FR.pdf | 001 | FR | 3 | 2026/05/12 |